{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T15:27:09Z","timestamp":1793287629739,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,6,13]],"date-time":"2018-06-13T00:00:00Z","timestamp":1528848000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1038\/s41431-018-0188-1","type":"journal-article","created":{"date-parts":[[2018,6,13]],"date-time":"2018-06-13T10:19:37Z","timestamp":1528885177000},"page":"1490-1496","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Isochromosome 21q is overrepresented among false-negative cell-free DNA prenatal screening results involving Down syndrome"],"prefix":"10.1038","volume":"26","author":[{"given":"Karin","family":"Huijsdens-van Amsterdam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieve","family":"Page-Christiaens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Flowers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D","family":"Bonifacio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie M Battese","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Else Marie","family":"Vestergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Miguelez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario Henrique Burlacchini","family":"de Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7187-4563","authenticated-orcid":false,"given":"Erik A","family":"Sistermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8363-2879","authenticated-orcid":false,"given":"Mark D","family":"Pertile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,13]]},"reference":[{"key":"188_CR1","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1056\/NEJMoa1311037","volume":"370","author":"DW Bianchi","year":"2014","unstructured":"Bianchi DW, Parker RL, Wentworth J, et al. DNA sequencing versus standard prenatal aneuploidy screening. N Engl J Med. 2014;370:799\u2013808.","journal-title":"N Engl J Med"},{"key":"188_CR2","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1056\/NEJMoa1407349","volume":"372","author":"ME Norton","year":"2015","unstructured":"Norton ME, Jacobsson B, Swamy GK, et al. Cell-free DNA analysis for noninvasive examination of trisomy. N Engl J Med. 2015;372:1589\u201397.","journal-title":"N Engl J Med"},{"key":"188_CR3","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/uog.17484","volume":"50","author":"MM Gil","year":"2017","unstructured":"Gil MM, Accurti V, Santacruz B, Plana MN, Nicolaides KH. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol. 2017;50:302\u201314.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"188_CR4","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/pd.4766","volume":"36","author":"PA Taneja","year":"2016","unstructured":"Taneja PA, Snyder HL, de Feo E, et al. Noninvasive prenatal testing in the general obstetric population: clinical performance and counseling considerations in over 85000 cases. Prenat Diagn. 2016;36:237\u201343.","journal-title":"Prenat Diagn"},{"key":"188_CR5","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/uog.14792","volume":"45","author":"H Zhang","year":"2015","unstructured":"Zhang H, Gao Y, Jiang F, et al. Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies. Ultrasound Obstet Gynecol. 2015;45:530\u20138.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"188_CR6","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/pd.5049","volume":"37","author":"TS Hartwig","year":"2017","unstructured":"Hartwig TS, Ambye L, Sorensen S, Jorgensen FS. Discordant non-invasive prenatal testing (NIPT)\u2013a systematic review. Prenat Diagn. 2017;37:527\u201339.","journal-title":"Prenat Diagn"},{"key":"188_CR7","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1373\/clinchem.2013.207951","volume":"60","author":"RP Rava","year":"2014","unstructured":"Rava RP, Srinivasan A, Sehnert AJ, Bianchi DW. Circulating fetal cell-free DNA fractions differ in autosomal aneuploidies and monosomy X. Clin Chem. 2014;60:243\u201350.","journal-title":"Clin Chem"},{"key":"188_CR8","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1093\/nar\/gkt992","volume":"42","author":"R Straver","year":"2014","unstructured":"Straver R, Sistermans EA, Holstege H, Visser A, Oudejans CB, Reinders MJ. WISECONDOR: detection of fetal aberrations from shallow sequencing maternal plasma based on a within-sample comparison scheme. Nucleic Acids Res. 2014;42:e31.","journal-title":"Nucleic Acids Res"},{"key":"188_CR9","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/pd.4615","volume":"35","author":"SK Kim","year":"2015","unstructured":"Kim SK, Hannum G, Geis J, et al. Determination of fetal DNA fraction from the plasma of pregnant women using sequence read counts. Prenat Diagn. 2015;35:810\u20135.","journal-title":"Prenat Diagn"},{"key":"188_CR10","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/pd.4816","volume":"36","author":"R Straver","year":"2016","unstructured":"Straver R, Oudejans CB, Sistermans EA, Reinders MJ. Calculating the fetal fraction for noninvasive prenatal testing based on genome-wide nucleosome profiles. Prenat Diagn. 2016;36:614\u201321.","journal-title":"Prenat Diagn"},{"issue":"405","key":"188_CR11","doi-asserted-by":"publisher","first-page":"eaan1240","DOI":"10.1126\/scitranslmed.aan1240","volume":"9","author":"Mark D. Pertile","year":"2017","unstructured":"Pertile MD, Halks-Miller M, Flowers N et al. Rare autosomal trisomies, revealed by maternal plasma DNA sequencing, suggest increased risk of feto-placental disease. Sci Transl Med. 2017; 30;9. pii: eaan1240. doi: 10.1126\/scitranslmed.aan1240.","journal-title":"Science Translational Medicine"},{"key":"188_CR12","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1002\/pd.4945","volume":"36","author":"D Oepkes","year":"2016","unstructured":"Oepkes D, Page-Christiaens GC, Bax CJ, et al. Trial by Dutch laboratories for evaluation of non-invasive prenatal testing. Part I-clinical impact. Prenat Diagn. 2016;36:1083\u201390.","journal-title":"Prenat Diagn"},{"key":"188_CR13","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ajog.2012.08.033","volume":"207","author":"KH Nicolaides","year":"2012","unstructured":"Nicolaides KH, Syngelaki A, Ashoor G, Birdir C, Touzet G. Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population. Am J Obstet Gynecol. 2012;207:374. e371-6","journal-title":"Am J Obstet Gynecol"},{"key":"188_CR14","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/pd.4103","volume":"33","author":"KH Nicolaides","year":"2013","unstructured":"Nicolaides KH, Syngelaki A, Gil M, Atanasova V, Markova D. Validation of targeted sequencing of single-nucleotide polymorphisms for non-invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y. Prenat Diagn. 2013;33:575\u20139.","journal-title":"Prenat Diagn"},{"key":"188_CR15","unstructured":"Willems PJ, Dierickx H, Segers N et al. High positive predictive value (PPV) of cell-free DNA (cfDNA) testing in a clinical study of 10,000 consecutive pregnancies. J Mol Biomark Diagn. 2016, 7: 285"},{"key":"188_CR16","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/uog.14664","volume":"45","author":"MS Quezada","year":"2015","unstructured":"Quezada MS, Gil MM, Francisco C, Orosz G, Nicolaides KH. Screening for trisomies 21, 18 and 13 by cell-free DNA analysis of maternal blood at 10-11 weeks\u2019 gestation and the combined test at 11\u201313 weeks. Ultrasound Obstet Gynecol. 2015;45:36\u201341.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"188_CR17","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/pd.4160","volume":"33","author":"Y Song","year":"2013","unstructured":"Song Y, Liu C, Qi H, Zhang Y, Bian X, Liu J. Noninvasive prenatal testing of fetal aneuploidies by massively parallel sequencing in a prospective Chinese population. Prenat Diagn. 2013;33:700\u20136.","journal-title":"Prenat Diagn"},{"key":"188_CR18","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1002\/pd.4212","volume":"33","author":"Y Wang","year":"2013","unstructured":"Wang Y, Zhu J, Chen Y, et al. Two cases of placental T21 mosaicism: challenging the detection limits of non-invasive prenatal testing. Prenat Diagn. 2013;33:1207\u201310.","journal-title":"Prenat Diagn"},{"key":"188_CR19","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1002\/pd.3993","volume":"32","author":"B Zimmermann","year":"2012","unstructured":"Zimmermann B, Hill M, Gemelos G, et al. Noninvasive prenatal aneuploidy testing of chromosomes 13, 18, 21, X, and Y, using targeted sequencing of polymorphic loci. Prenat Diagn. 2012;32:1233\u201341.","journal-title":"Prenat Diagn"},{"key":"188_CR20","doi-asserted-by":"publisher","first-page":"e0133151","DOI":"10.1371\/journal.pone.0133151","volume":"10","author":"W Zhao","year":"2015","unstructured":"Zhao W, Chen F, Wu M, et al. Postnatal identification of trisomy 21: an overview of 7,133 postnatal trisomy 21 cases identified in a diagnostic reference laboratory in China. PLoS ONE. 2015;10:e0133151.","journal-title":"PLoS ONE"},{"key":"188_CR21","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1002\/ajmg.1320470818","volume":"47","author":"LG Shaffer","year":"1993","unstructured":"Shaffer LG, McCaskill C, Haller V, Brown JA, Jackson-Cook CK. Further characterization of 19 cases of rea(21q21q) and delineation as isochromosomes or Robertsonian translocations in Down syndrome. Am J Med Genet. 1993;47:1218\u201322.","journal-title":"Am J Med Genet"},{"key":"188_CR22","first-page":"290","volume":"54","author":"WP Robinson","year":"1994","unstructured":"Robinson WP, Bernasconi F, Basaran S, et al. A somatic origin of homologous Robertsonian translocations and isochromosomes. Am J Hum Genet. 1994;54:290\u2013302.","journal-title":"Am J Hum Genet"},{"key":"188_CR23","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/pd.620","volume":"23","author":"S Brisset","year":"2003","unstructured":"Brisset S, Aboura A, Audibert F, et al. Discordant prenatal diagnosis of trisomy 21 due to mosaic structural rearrangements of chromosome 21. Prenat Diagn. 2003;23:461\u20139.","journal-title":"Prenat Diagn"},{"key":"188_CR24","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1002\/pd.425","volume":"22","author":"JL Gilardi","year":"2002","unstructured":"Gilardi JL, Perrotin F, Paillet C, et al. Prenatal diagnosis of trisomy 21 by i(21q): a rare case of fetoplacental chromosomal discrepancy. Prenat Diagn. 2002;22:856\u20138.","journal-title":"Prenat Diagn"},{"key":"188_CR25","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/pd.1383","volume":"26","author":"M Riegel","year":"2006","unstructured":"Riegel M, Wisser J, Baumer A, Schinzel A. Postzygotic isochromosome formation as a cause for false-negative results from chorionic villus chromosome examinations. Prenat Diagn. 2006;26:221\u20135.","journal-title":"Prenat Diagn"},{"key":"188_CR26","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1016\/j.gyobfe.2011.07.054","volume":"39","author":"J Caloone","year":"2011","unstructured":"Caloone J, Sanlaville D, Fichez A, Abel C, Huissoud C, Rudigoz RC. Trisomy 21 by isochromosome: a case report of true false negative of chorionic villi sampling. Gynecol Obstet Fertil. 2011;39:e77\u201380.","journal-title":"Gynecol Obstet Fertil"},{"key":"188_CR27","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/ajmg.1320460517","volume":"46","author":"DW Bianchi","year":"1993","unstructured":"Bianchi DW, Wilkins-Haug LE, Enders AC, Hay ED. Origin of extraembryonic mesoderm in experimental animals: relevance to chorionic mosaicism in humans. Am J Med Genet. 1993;46:542\u201350.","journal-title":"Am J Med Genet"},{"key":"188_CR28","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1093\/humrep\/deh117","volume":"19","author":"E Flori","year":"2004","unstructured":"Flori E, Doray B, Gautier E, et al. Circulating cell-free fetal DNA in maternal serum appears to originate from cyto- and syncytio-trophoblastic cells. Case report. Hum Reprod. 2004;19:723\u20134.","journal-title":"Hum Reprod"},{"key":"188_CR29","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1002\/pd.5079","volume":"37","author":"DM Beek van","year":"2017","unstructured":"van Beek DM, Straver R, Weiss MM, et al. Comparing methods for fetal fraction determination and quality control of NIPT samples. Prenat Diagn. 2017;37:769\u201373.","journal-title":"Prenat Diagn"},{"key":"188_CR30","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1002\/uog.17483","volume":"49","author":"LJ Salomon","year":"2017","unstructured":"Salomon LJ, Alfirevic Z, Audibert F, et al. ISUOG updated consensus statement on the impact of cfDNA aneuploidy testing on screening policies and prenatal ultrasound practice. Ultrasound Obstet Gynecol. 2017;49:815\u20136.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"188_CR31","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/pd.4123","volume":"33","author":"T Futch","year":"2013","unstructured":"Futch T, Spinosa J, Bhatt S, de Feo E, Rava RP, Sehnert AJ. Initial clinical laboratory experience in noninvasive prenatal testing for fetal aneuploidy from maternal plasma DNA samples. Prenat Diagn. 2013;33:569\u201374.","journal-title":"Prenat Diagn"},{"key":"188_CR32","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/pd.4278","volume":"34","author":"M Stumm","year":"2014","unstructured":"Stumm M, Entezami M, Haug K, et al. Diagnostic accuracy of random massively parallel sequencing for non-invasive prenatal detection of common autosomal aneuploidies: a collaborative study in Europe. Prenat Diagn. 2014;34:185\u201391.","journal-title":"Prenat Diagn"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41431-018-0188-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41431-018-0188-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41431-018-0188-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T20:58:05Z","timestamp":1684616285000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-018-0188-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,13]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["188"],"URL":"https:\/\/doi.org\/10.1038\/s41431-018-0188-1","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,13]]},"assertion":[{"value":"10 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Lieve Page-Christiaens is Associate Medical Director at Illumina, Inc. San Diego and holds equity in Illumina. The remaining authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}